PuraPharm Corp Ltd

PuraPharm Corp Ltd has a basic and diluted share count of 535,897,647 shares outstanding, indicating no immediate dilution pressure from share-based compensation or convertible instruments. However, the company's liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents.

The company reported a loss per share of -0.33 HKD in the latest period, reflecting a negative earnings performance. Revenue for the same period was 695,879,000 HKD, but without access to industry_config preferred metrics or cohort medians, a direct comparison to industry benchmarks is not possible.

Segment and geographic exposure data are not available in the current dataset, limiting the ability to assess revenue concentration or geographic diversification. This lack of detail prevents a comprehensive evaluation of the company's operational risk profile.

The company's growth trajectory is unclear due to the absence of historical revenue data and forward-looking guidance. Analysts have not provided estimates for the next fiscal year, and no numeric deltas are available to assess potential growth or contraction.

Risk factors include the inability to assess liquidity risk, which could impact the company's ability to meet short-term obligations. Additionally, the absence of detailed financial disclosures limits the ability to evaluate credit risk or capital structure stability.

Recent events, including filings and transcripts, are not available in the current dataset, preventing an assessment of management commentary or strategic developments.

Revenue HK$336.1M, −12,0% YoY; Operating income −165,7% YoY.

• ▍Revenue HK$336.1M, −12,0% YoY
• ▍Operating income −165,7% YoY
• ▍Net income +0,6% YoY
• ▍Net margin -10.5%

Revenue HK$382.1M, −6,1% YoY; Operating income +93,2% YoY.

• ▍Revenue HK$382.1M, −6,1% YoY
• ▍Operating income +93,2% YoY
• ▍Net income +66,6% YoY
• ▍Free cash flow +103,5% YoY
• ▍Net margin -9.3%

Revenue HK$406.9M, −9,2% YoY; Operating income +21,3% YoY.

• ▍Revenue HK$406.9M, −9,2% YoY
• ▍Operating income +21,3% YoY
• ▍Net income +11,8% YoY
• ▍Free cash flow +16,8% YoY
• ▍Net margin -26.1%

Revenue HK$448.1M, −32,1% YoY; Operating income −5,4% YoY.

• ▍Revenue HK$448.1M, −32,1% YoY
• ▍Operating income −5,4% YoY
• ▍Net income +1,4% YoY
• ▍Free cash flow −21,5% YoY
• ▍Net margin -26.8%

Revenue HK$659.6M; Operating income -HK$90.2M.

• ▍Revenue HK$659.6M
• ▍Operating income -HK$90.2M
• ▍Net margin -18.5%